FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2755141287> ?p ?o ?g. }

• W2755141287 endingPage "858" @default.
• W2755141287 startingPage "852" @default.
• W2755141287 abstract "The starting dose for narrowband UV-B phototherapy is determined by a patient's skin phototype or minimal erythema dose (MED). Calculation of MED identifies patients with unsuspected photosensitivity. The aim of this study was to investigate the influence of factors such as concomitant use of photosensitizing agents, diagnosis, and combination with acitretin in patients with psoriasis on the frequency and severity of adverse effects in patients with a low MED to narrowband UV-B phototherapy. We undertook a retrospective observational cohort study between February 1, 2009 and March 31, 2015. MED values were classified as normal or low. In total, 302 patients with different skin conditions started narrowband UV-B phototherapy at a dose determined by their MED. No differences were found between patients with a low MED and those with a normal MED for number of drugs taken (P = .071) or use of photosensitizing agents (P = 0.806). Following adjustment for age, sex, and phototype, the multivariate analysis showed that psoriasis exerted a protective effect against a low MED (OR = 0.31 [95% CI, 0.16-0.58]). No significant risk of erythema or pruritus was detected in patients with a low MED (OR = 1.68; 95% CI, 0.91-3.29 and OR = 2.04; 95% CI, 0.99-4.22, respectively). Psoriasis protects against a low MED. Although erythema and pruritus were more common in patients with a low MED, the differences were not significant. La dosis de inicio en la fototerapia UVB de banda estrecha (UVBBE) viene determinada por el fototipo o por la determinación de la dosis eritematógena mínima (DEM). El cálculo de la DEM identifica pacientes con fotosensibilidad no sospechada. El objetivo de nuestro estudio es conocer la influencia que puedan tener en una DEM disminuida los fármacos fotosensibilizantes concomitantes, el diagnóstico, la asociación con acitretina en pacientes con psoriasis y evidenciar si la DEM alterada provoca más reacciones adversas y más graves. Se trata de un estudio observacional de una cohorte retrospectiva desde el período comprendido entre el 1 de febrero de 2009 al 31 de marzo de 2015. La determinación de la DEM se categorizó en DEM normal o patológica. Trescientos dos pacientes con distintas dermatosis inician UVBBE en función de la DEM. No se han encontrado diferencias entre el grupo con DEM patológica respecto al normal, ni en el número de fármacos consumidos (p = 0,071), ni en el potencial fotosensibilizante (p = 0,806). El análisis multivariante ajustado por edad, sexo y fototipo reveló que la psoriasis es un factor protector de DEM patológica (OR = 0,31 [IC 95%: 0,16-0,58]). No se encontró riesgo significativo de eritema ni prurito en los pacientes con DEM alterada OR = 1,68 (IC 95%: 0,91-3,29) y OR = 2,04 (IC 95%: 0,99-4,22), respectivamente. La psoriasis protege de tener una DEM patológica. Si bien el eritema y el prurito fueron más frecuentes en los pacientes con DEM patológica, las diferencias no fueron estadísticamente significativas." @default.
• W2755141287 created "2017-09-25" @default.
• W2755141287 creator A5004418523 @default.
• W2755141287 creator A5025019837 @default.
• W2755141287 creator A5029271190 @default.
• W2755141287 creator A5047971647 @default.
• W2755141287 creator A5056867501 @default.
• W2755141287 creator A5091492547 @default.
• W2755141287 date "2017-11-01" @default.
• W2755141287 modified "2023-10-18" @default.
• W2755141287 title "Is it Useful to Calculate Minimal Erythema Dose Before Narrowband UV-B Phototherapy?" @default.
• W2755141287 cites W1483263365 @default.
• W2755141287 cites W1943764296 @default.
• W2755141287 cites W1975453035 @default.
• W2755141287 cites W1979472148 @default.
• W2755141287 cites W1996295606 @default.
• W2755141287 cites W1996446786 @default.
• W2755141287 cites W2000260459 @default.
• W2755141287 cites W2006087295 @default.
• W2755141287 cites W2014224812 @default.
• W2755141287 cites W2017119606 @default.
• W2755141287 cites W2018241675 @default.
• W2755141287 cites W2019974537 @default.
• W2755141287 cites W2020436885 @default.
• W2755141287 cites W2026369097 @default.
• W2755141287 cites W2049069033 @default.
• W2755141287 cites W2055940612 @default.
• W2755141287 cites W2066252970 @default.
• W2755141287 cites W2074360457 @default.
• W2755141287 cites W2075801366 @default.
• W2755141287 cites W2079804943 @default.
• W2755141287 cites W2104866882 @default.
• W2755141287 cites W2114160915 @default.
• W2755141287 cites W2130597579 @default.
• W2755141287 cites W2136866832 @default.
• W2755141287 cites W2165783512 @default.
• W2755141287 cites W2319930053 @default.
• W2755141287 cites W2398398717 @default.
• W2755141287 cites W4234659973 @default.
• W2755141287 doi "https://doi.org/10.1016/j.adengl.2017.08.019" @default.
• W2755141287 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28687116" @default.
• W2755141287 hasPublicationYear "2017" @default.
• W2755141287 type Work @default.
• W2755141287 sameAs 2755141287 @default.
• W2755141287 citedByCount "2" @default.
• W2755141287 countsByYear W27551412872018 @default.
• W2755141287 countsByYear W27551412872023 @default.
• W2755141287 crossrefType "journal-article" @default.
• W2755141287 hasAuthorship W2755141287A5004418523 @default.
• W2755141287 hasAuthorship W2755141287A5025019837 @default.
• W2755141287 hasAuthorship W2755141287A5029271190 @default.
• W2755141287 hasAuthorship W2755141287A5047971647 @default.
• W2755141287 hasAuthorship W2755141287A5056867501 @default.
• W2755141287 hasAuthorship W2755141287A5091492547 @default.
• W2755141287 hasBestOaLocation W27551412871 @default.
• W2755141287 hasConcept C126322002 @default.
• W2755141287 hasConcept C16005928 @default.
• W2755141287 hasConcept C167135981 @default.
• W2755141287 hasConcept C197934379 @default.
• W2755141287 hasConcept C2779121184 @default.
• W2755141287 hasConcept C2779384505 @default.
• W2755141287 hasConcept C2780564577 @default.
• W2755141287 hasConcept C2780846639 @default.
• W2755141287 hasConcept C71924100 @default.
• W2755141287 hasConceptScore W2755141287C126322002 @default.
• W2755141287 hasConceptScore W2755141287C16005928 @default.
• W2755141287 hasConceptScore W2755141287C167135981 @default.
• W2755141287 hasConceptScore W2755141287C197934379 @default.
• W2755141287 hasConceptScore W2755141287C2779121184 @default.
• W2755141287 hasConceptScore W2755141287C2779384505 @default.
• W2755141287 hasConceptScore W2755141287C2780564577 @default.
• W2755141287 hasConceptScore W2755141287C2780846639 @default.
• W2755141287 hasConceptScore W2755141287C71924100 @default.
• W2755141287 hasIssue "9" @default.
• W2755141287 hasLocation W27551412871 @default.
• W2755141287 hasOpenAccess W2755141287 @default.
• W2755141287 hasPrimaryLocation W27551412871 @default.
• W2755141287 hasRelatedWork W1578809130 @default.
• W2755141287 hasRelatedWork W2039876145 @default.
• W2755141287 hasRelatedWork W2116945410 @default.
• W2755141287 hasRelatedWork W2138040583 @default.
• W2755141287 hasRelatedWork W2341815245 @default.
• W2755141287 hasRelatedWork W2390441009 @default.
• W2755141287 hasRelatedWork W2390472152 @default.
• W2755141287 hasRelatedWork W2587864234 @default.
• W2755141287 hasRelatedWork W2613327813 @default.
• W2755141287 hasRelatedWork W2716977361 @default.
• W2755141287 hasVolume "108" @default.
• W2755141287 isParatext "false" @default.
• W2755141287 isRetracted "false" @default.
• W2755141287 magId "2755141287" @default.
• W2755141287 workType "article" @default.